Reaktionsgleichung
[Cl:1][C:2]1[C:10]2[C:5](=[N:6][CH:7]=[CH:8][CH:9]=2)[S:4][CH:3]=1.C([Li])CCC.CCCCCC.[CH2:22]([CH:24]([C:27]1[C:28]2[N:29]([C:34](I)=[C:35]([CH3:37])[N:36]=2)[N:30]=[C:31]([CH3:33])[CH:32]=1)[CH2:25][CH3:26])[CH3:23]>C1COCC1.[Cl-].[Cl-].[Zn+2].C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.Cl[Pd]Cl.[Fe+2]>[Cl:1][C:2]1[C:10]2[C:5](=[N:6][CH:7]=[CH:8][CH:9]=2)[S:4][C:3]=1[C:34]1[N:29]2[N:30]=[C:31]([CH3:33])[CH:32]=[C:27]([CH:24]([CH2:22][CH3:23])[CH2:25][CH3:26])[C:28]2=[N:36][C:35]=1[CH3:37]Komponenten
Edukt 4
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 3
Reaktionsbedingungen
- Temperatur
- -78 °C
Versuchsvorschrift
250 mg of 3-Chloro-thieno[2,3-b]pyridine (1.5 mmol) is dissolved in 2.0 ml of dry THF and cooled to −78° C. 0.59 ml of n-butyl lithium 2.5 M in hexane (1.5 mmol) is added slowly and stirred at room temperature for 3 min and cooled to −78° C. 3.0 ml of 0.5 M ZnCl2 in THF (1.5 mmol) is added and stirred at room temperature for 20 min. 343 mg of 8-(1-ethyl-propyl)-3-iodo-2,6-dimethyl-imidazo[1,2-b]pyridazine (1.0 mmol) and 41 mg of PdCl2(dppf) (0.05 mmol) are added and the reaction vial is capped with a Teflon cap and heated at 80° C. overnight. The reaction mixture is concentrated and applied onto a chromatography silica-gel column (Hexane:AcOEt=3:1); mass spectrum (m/e): 385; 1H-NMR (CDCl3): 8.66 (dd, 1H, J=4.5 Hz, 1.5 Hz), 8.10 (dd, 1H, J=8.1 Hz, 1.5 Hz), 7.44 (1H, J=8.1 Hz, 4.5 Hz), 6.74 (s, 1H), 3.33 (m, 1H), 2.55 (s, 3H), 2.53 (s, 3H), 1.85 (m, 4H), 0.89 (t, 6H, J=7.5 Hz) ppm.
Aufarbeitung
- temperaturecooled to −78° C
- stirringstirred at room temperature for 20 min
- customthe reaction
- customcap
- temperatureheated at 80° C. overnight
- concentrationThe reaction mixture is concentrated
Quellen und Nachweise
- ORD-Eintrag
- ord-77a5ccbc089b4af9a27ad748123c229e
- Quelldatensatz
- uspto-grants-2009_07
- Patentnummer
- US07557103B2
Verknüpfte Notizen
Wird geladen…